Modification of dopa toxicity in human tumour cells
- 1 May 1985
- journal article
- research article
- Published by Elsevier in Biochemical Pharmacology
- Vol. 34 (10) , 1801-1807
- https://doi.org/10.1016/0006-2952(85)90652-5
Abstract
No abstract availableThis publication has 24 references indexed in Scilit:
- The Chemotherapy of Malignant MelanomaJournal of Investigative Dermatology, 1983
- 3,4-Dihydroxybenzylamine: An Improved Dopamine Analog Cytotoxic for Melanoma Cells in Part Through Oxidation Products Inhibitory to DNA PolymeraseJournal of Investigative Dermatology, 1983
- Ascorbate-Cu2+ fragments melanoma DNA but not fibroblast DNA into a discrete DNA populationCarcinogenesis: Integrative Cancer Research, 1983
- Mammalian Tyrosinase Catalyzes Three Reactions in the Biosynthesis of MelaninScience, 1982
- Regulation of ribonucleotide reductase in mammalian cells by chemotherapeutic agentsAdvances in Enzyme Regulation, 1981
- An Experimental Approach to the Chemotherapy of MelanomaJournal of Investigative Dermatology, 1980
- L-Dopa Methyl Ester: Prolongation of Survival of Neuroblastoma-Bearing Mice After TreatmentScience, 1978
- L-Dopa methyl ester as a new antitumour agentNature, 1977
- L-Dopa: Selective Toxicity for Melanoma Cells in VitroScience, 1977
- Antitumour activity of dopa, dopamine, noradrenalin or adrenalin and their reaction with nucleic acidsZeitschrift für Krebsforschung und Klinische Onkologie, 1970